The Impact of Nonadherence to Inhaled Long-Acting β 2 -Adrenoceptor Agonist/Corticosteroid Combination Therapy on Healthcare Costs in Difficult-to-Control Asthma

Author： O'Neill Ciaran   Gamble Jacqui   Lindsay John T.   Heaney Liam G.  

Publisher： Adis International

ISSN： 1178-2595

Source： Pharmaceutical Medicine, Vol.25, Iss.6, 2011-12, pp. : 379-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using a single inhaler device containing an inhaled corticosteroid plus a long-acting β-adrenoceptor agonist is a practical approach in patients with moderate to severe asthma

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 3, 2008-03 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

By Kim Dennis   Glaum Mark   Lockey Richard  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

Combination Therapy of Inhaled Corticosteroids and Long-Acting &bgr;2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3547-3560

Bentham Science Publishers

Access to resources Recommend Favorite

The effects of formoterol, a long-acting 2 -adrenoceptor agonist, on mucociliary activity

By Lindberg S.   Khan R.   Runer T.  

European Journal of Pharmacology, Vol. 285, Iss. 3, 1995-10 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite